Study on the pathogenesis of Wegener's granulomatosis
Study on the pathogenesis of Wegener's granulomatosis
批准号:
06671700
负责人:
INUYAMA Yukio
金额:
$1.34万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1995
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This study examined the role of adhesion molecules in the pathogenesis of Wegener's granulomatosis (WG). For the cytokine, the titers of tumor necrosis factor-alpha (TNF-alpha) are not so high even in the active stage of the disease. The value of soluble ICAM-1 (inter-cellular adhesion molecule-1) in the active stage are significantly high compared with those in the inactive stage of the disease or in healthy volunteers. When we examined the sera of patients individually, the level of soluble ICAM-1 decreases gradually as the disease recover, and the correlation of them was apparently demonstrated. This result means that adhesion of the neutrophils with LFA-1 on its surface take place with the vascular endothelial cells in this disease. However, SLeX or LFA-1, the ligand of the neutrophil, was not revealed to become apparent when activated with TNF-alpha or cANCA (cytoplasmic-antineutrophil cytoplasmic antibody) lgG.It is supposed that integrin such as LFA-1 has two forms, resting form and active form, and its conformational change alter the affinity for the ligand. Further study is needed for this problem.The study also examined the association between various human leukocyte antigens (HLA) and cANCA-positive WG in Japanese subjects to determine whether HLA antigens are involved in the pathogenesis of this disease. The study involved 16 subjects with cANCA-positive WG treated in our department. HLA-typing of the lymphocytes was performed using a lymphocyte microcytotoxicity assay. Of the subjects with cANCA-positive WG,62.5% (10/16) were positive for HLA-DR9, compared with 26% of the healthy control subjects. This HLA-DR9 elevation was statistically significant (P<0.01, Pc<0.05) ; we also noted a weaker association between HLA-B55 and cANCA-positive WG (P<0.05). The results indicated that an association may exist between certain HLA-class allotypes and WG.
期刊论文(15)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
間口四郎、滝沢昌彦他: "Wegener肉芽腫症の診断と治療-耳鼻咽喉科の立場から-" 耳鼻頭頸. 67. 932-940 (1995)
Shiro Maguchi、Masahiko Takizawa 等人:“韦格纳肉芽肿病的诊断和治疗 - 从耳鼻喉科的角度”Otorhinolaryngology 67. 932-940 (1995)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Nakamaru Y: "Association of c-ANCA positive Wegener's granulomatosis with HLA antigens in Japanese patients" Rhinology in press.
Nakamaru Y:“日本患者 c-ANCA 阳性韦格纳肉芽肿与 HLA 抗原的关联”《鼻科》出版。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Nakamaru Y,Maguchi S et al.: "Association of c-ANCA positive Wegener's granulomatosis with HLA antigens in Japanese patients" Rhinology. (in press).
Nakamaru Y、Maguchi S 等人:“日本患者中 c-ANCA 阳性韦格纳肉芽肿与 HLA 抗原的关联”鼻科。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
間口四郎、滝沢昌彦他: "Wegener肉芽腫症の治療とネフロスカラー・C-ANCによる抗好中球細胞質抗体価の変動" 日耳鼻. 98. 974-983 (1995)
Shiro Maguchi、Masahiko Takizawa 等人:“Wegener 肉芽肿病的治疗和肾盂/C-ANC 引起的抗中性粒细胞胞浆抗体滴度的变化”Nippo Otolaryngology 98. 974-983 (1995)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Shiroh Maguchi, Yukio Inuyama et al.: "Diagnosis and treatment of Wegener's granulomatosis" Jibi inkoka Tokeibu Geka. vol.67. 932-940 (1995)
Shiroh Maguchi、Yukio Inuyama 等:“韦格纳肉芽肿病的诊断和治疗”Jibi inkoka Tokeibu Geka。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 11 条
Investigation on CDDP resistance of Head and Neck Cancer.
-
批准号:11470352
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$4.74万
-
财政年份:1999
-
负责人:INUYAMA Yukio
-
依托单位:
Studies on concurrent radiotherapy and chemotherapy to point to preservation of the prgan and function for head and neck cancer
-
批准号:08671944
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.54万
-
财政年份:1996
-
负责人:INUYAMA Yukio
-
依托单位:
Basic and clinical studies on an overcome of drug resistance inchemotherapy for heas and neck cancer
-
批准号:04671027
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1992
-
负责人:INUYAMA Yukio
-
依托单位:
Studies on Development of Non-Cross Resistant Chemotherapy for Head and Neck Cancer
-
批准号:01570961
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1989
-
负责人:INUYAMA Yukio
-
依托单位:
Studies on chemotherapy of advanced or recurrent head and neck cancer for purposes of prolongation of life with improvement of quality of life
-
批准号:62570784
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1987
-
负责人:INUYAMA Yukio
-
依托单位:
Studies on development of a new multidisciplinary treatment incorporating neo-adjuvant chemotherapy for head and neck cancer
-
批准号:60570820
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.09万
-
财政年份:1985
-
负责人:INUYAMA Yukio
-
依托单位:
国内基金
海外基金
登录
查看更多内容
血小板来源的HMGB1促进中性粒细胞NETs形成诱导ANCA相关性血管炎内皮细胞损伤的机制研究
-
批准号:2024Y9218
-
项目类别:省市级项目
-
资助金额:25.0万元
-
批准年份:2024
-
负责人:王宇佳
-
依托单位:
YB-1 介导肾小球壁层上皮细胞 Notch1/Hey2 通路活化在 ANCA 相关肾小球肾
炎中的作用机制研究
-
批准号:24ZR1411100
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:王嘉琳
-
依托单位:
CXCL12/CXCR4介导巨噬细胞胞葬作用促进MPO-ANCA相关性肾炎纤维化的机制研究
-
批准号:CSTB2023NSCQ-MSX0129
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2023
-
负责人:王墨
-
依托单位:
S1PR2调节中性粒细胞脂肪酸氧化在ANCA相关小血管炎中的作用及机制研究
-
批准号:82300817
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:王洛依
-
依托单位:
hucMSC-Exo递送miR-129-1-3p靶向TRAF3抑制NETs治疗ANCA相关性血管炎
-
批准号:2023JJ30554
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:朱艳
-
依托单位:
CD103+CD8+组织驻留记忆T细胞与中性粒细胞互作参与ANCA相关性血管炎发病机制的研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:50万元
-
批准年份:2022
-
负责人:张静波
-
依托单位:
颗粒蛋白前体与C5a相互作用介导ANCA相关小血管炎细胞活化及凝血调控机制研究
-
批准号:82260146
-
项目类别:地区科学基金项目
-
资助金额:34万元
-
批准年份:2022
-
负责人:郝健
-
依托单位:
线粒体损伤相关分子模式(mtDAMPs)增强ANCA活化的中性粒细胞在血管炎中致病作用的机制
-
批准号:82170726
-
项目类别:面上项目
-
资助金额:55.00万元
-
批准年份:2021
-
负责人:徐鹏程
-
依托单位:
Th9 细胞在ANCA 相关小血管炎中促进肾脏炎症损伤的作用及机制研究
-
批准号:2021JJ31130
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:钟永
-
依托单位:
线粒体损伤相关分子模式(mtDAMPs)增强ANCA活化的中性粒细胞在血管炎中致病作用的机制
-
批准号:--
-
项目类别:--
-
资助金额:55万元
-
批准年份:2021
-
负责人:徐鹏程
-
依托单位: